Merigan, T C <br/><br/>
The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.  [electronic resource] 

 -  AIDS (London, England)  Feb 1996 
 - 159-65 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/00002030-199602000-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>Antigen-Antibody Complex<br/>Antiviral Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>Disease Progression<br/>Double-Blind Method<br/>Female<br/>HIV Core Protein p24--blood<br/>HIV Infections--drug therapy<br/>HIV Reverse Transcriptase--genetics<br/>HIV-1<br/>Humans<br/>Male<br/>Mutation<br/>Predictive Value of Tests<br/>Prognosis<br/>RNA, Viral--blood<br/>Retrospective Studies<br/>Thymopentin--therapeutic use<br/>Viral Load<br/>Zidovudine--therapeutic use